Discontinuation Of Tumor Necrosis Factor Inhibitors In Rheumatoid Arthritis Patients In Low Disease Activity: Persistent Benefits.

被引：0
|
作者：
Kavanaugh, Arthur [1 ]
Lee, Susan J. [1 ]
Solomon, Daniel H. [2 ]
Greenberg, Jeffrey D. [3 ]
Kremer, Joel M. [4 ]
Soto, Lilian [5 ]
Etzel, Carol J. [6 ]
Reed, George W. [7 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol,Div Pharmacoepidemiol, Boston, MA 02115 USA
[3] NYU, Hosp Joint Dis, New York, NY USA
[4] Albany Med Coll, Ctr Rheumatol, Albany, NY 12208 USA
[5] Univ Calif San Diego, San Diego, CA 92103 USA
[6] CORRONA Inc, Houston, TX USA
[7] CORRONA Inc, Worcester, MA USA
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1425
引用
收藏
页码：S603 / S603
页数：1
相关论文
共 50 条
  • [31] Metabolic Responses to Change in Disease Activity during Tumor Necrosis Factor Inhibition in Patients with Rheumatoid Arthritis
    Madsen, Rasmus
    Rantapaa-Dahlqvist, Solbritt
    Lundstedt, Torbjorn
    Moritz, Thomas
    Trygg, Johan
    [J]. JOURNAL OF PROTEOME RESEARCH, 2012, 11 (07) : 3796 - 3804
  • [32] ANTI-TUMOR NECROSIS FACTOR SWITCHING, DISCONTINUATION, AND PERSISTENCE IN MANAGED CARE PATIENTS WITH RHEUMATOID ARTHRITIS
    Buysman, E.
    Tang, B.
    Carter, C.
    Piech, C. T.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A128 - A128
  • [33] Comparative Effectiveness of Tocilizumab Monotherapy with Tumor Necrosis Factor Inhibitors in Combination with Methotrexate in Patients with Rheumatoid Arthritis and Prior Exposure to Tumor Necrosis Factor Inhibitors
    Harrold, Leslie R.
    Reed, George W.
    Best, Jennie
    Zlotnick, Steve
    Persuitte, Gioia
    Kremer, Joel M.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [34] Tumor necrosis factor inhibitors: New options for treating rheumatoid arthritis
    Moreland, LW
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2001, 3 (09): : 686 - 690
  • [35] The Effects of Tumor Necrosis Factor Inhibitors on Cardiovascular Risk in Rheumatoid Arthritis
    Peters, Mike J. L.
    van Sijl, Alper M.
    Voskuyl, Alexandre E.
    Sattar, Naveed
    Smulders, Yvo M.
    Nurmohamed, Michael T.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (11) : 1502 - 1511
  • [36] Tumor necrosis factor inhibitors: New options for treating rheumatoid arthritis
    [J]. Moreland, L.W. (larry.moreland@ccc.uab.edu), 2001, Israel Medical Association (03):
  • [37] Tumor Necrosis Factor Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis
    Nicoletta Luciano
    Elisa Barone
    Suraj Timilsina
    M. Eric Gershwin
    Carlo Selmi
    [J]. Clinical Reviews in Allergy & Immunology, 2023, 65 : 403 - 419
  • [38] Inhibitors of tumor necrosis factor: New treatment options for rheumatoid arthritis
    Moreland, LW
    [J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 1999, 66 (06) : 367 - 374
  • [39] Tumor Necrosis Factor Alpha Inhibitors and Cardiovascular Risk in Rheumatoid Arthritis
    Luciano, Nicoletta
    Barone, Elisa
    Timilsina, Suraj
    Gershwin, M. Eric
    Selmi, Carlo
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2023, 65 (03) : 403 - 419
  • [40] Effect of tumor necrosis factor inhibitors on interstitial lung disease in rheumatoid arthritis: angel or demon?
    Huang, Ying
    Lin, Weiji
    Chen, Zhe
    Wang, Yu
    Huang, Yao
    Tu, Shenghao
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2019, 13 : 2111 - 2124
12345